Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J. S.
Right arrow Articles by Baker, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, J. S.
Right arrow Articles by Baker, D. C.
Vet Pathol 43:726-732 (2006)
© 2006 American College of Veterinary Pathologists

Defective {gamma}-Glutamyl Carboxylase Activity and Bleeding in Rambouillet Sheep

J. S. Johnson, B. A. Soute, C. S. Olver and D. C. Baker

Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO (JSJ, CSO, DCB), Department of Biochemistry, University of Limburg, Maastricht, The Netherlands (BAS)


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 
A flock of Rambouillet sheep was examined because of increased lamb mortality caused by ineffective hemostasis at parturition. Neonatal-affected lambs presented with inadequate hemostasis at the umbilicus, pale mucus membranes, and markedly prolonged activated clotting time. Affected lambs had consistently prolonged 1-stage prothrombin times and activated partial thromboplastin times that supported a defect in the common pathway or defects in both the intrinsic and extrinsic pathway of the coagulation cascade. Decreased activity of vitamin K-dependent procoagulant factors II, VII, IX, and X in male and female lambs suggested either a defect of the hepatic enzyme {gamma}-glutamyl carboxylase, or vitamin K1 2,3 epoxide reductase. Affected lamb hepatic {gamma}-glutamyl carboxylase activity was markedly decreased compared with that of age- and sex-matched control lambs, while vitamin K1 2,3 epoxide reductase and glucose-6-phosphatase activities were similar between an affected and normal lamb. Subcutaneous vitamin K1 supplementation did not increase vitamin K-dependent procoagulant factor activities in 3 lambs administered vitamin K1 daily. These data confirm defective {gamma}-glutamyl carboxylase activity as the cause of impaired coagulation of sheep in this flock. This flock represents the only viable animal model of hereditarily defective {gamma}-glutamyl carboxylase activity.

Key words: Gamma-glutamyl carboxylase; hemostasis; sheep; vitamin K.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 
Vitamin K is a cofactor for the posttranslational enzymatic reaction in which {gamma}-glutamyl carboxylase converts glutamic acid (Glu) residues to {gamma}-carboxylated glutamic acid (Gla).30,31 Specifically, gamma carboxylation is the addition of a carboxyl group to the gamma carbon of Glu12 and occurs on the inner surface of the endoplasmic reticulum.8 Proteins that share this processing before being secreted are referred to as vitamin K–dependent (VKD) proteins. Posttranslational modification occurs for VKD proteins involved in hemostasis, bone metabolism, mineralization, growth control, signal transduction, and cell survival.4,6,13,24 Gamma carboxylation allows calcium binding and activation of VKD proteins II, VII, IX, X; protein C; protein S;13 and osteocalcin-hydroxyapatite binding in bone.

The energy for this reaction is provided through the oxidation of vitamin K hydroquinone (K1H2) subsequent to binding the propeptide region of VKD proteins to Gla (Fig. 1).5,12 Calcium-binding Gla residues are formed from Glu residues, and K1H2 is converted to vitamin K1 2,3 epoxide. The vitamin K1 2,3 epoxide is reduced to vitamin K1H2, in a 2-step process by vitamin K epoxide reductase, an enzyme sensitive to inhibition by warfarin and other vitamin K antagonists. {gamma}-Carboxylation of coagulation proteins allows them to fold properly and bind receptors to participate in a series of reactions that either regulate or promote the formation of a stable fibrin clot.11


Figure 01
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 1 The vitamin K cycle. DTT = dithiothreitol. Glutamic acid (Glu) is carboxylated to {gamma}-carboxyl glutamic acid (Gla), and vitamin K1H2 is oxidized to yield H20 and vitamin K1 2,3 epoxide. Vitamin K1 2,3 epoxide is reduced to vitamin K1H2 by pathway #2 at physiologic concentrations of vitamin K by epoxide reductase possibly by using DTT as an electron donor and by pathway #1 by an NAD(P)H reductase (DT-diaphorase) at supraphysiologic concentrations of vitamin K.33 Pathway #2 is inhibited by warfarin. Pathway #1 is not.

 
We report a coagulopathy because of defective Gla activity in Rambouillet sheep similar to that described in human beings.6,7,10,15,20,23,26 A preliminary report that investigated this sheep flock demonstrated selective reduction of VKD coagulation factor activities and eliminated vitamin K antagonism or the presence of a circulating inhibitor as a cause for bleeding.1 Affected lambs were born alive but lacked the ability to achieve hemostasis of the umbilical artery and vein. Without intervention, newborn lambs continually bled from the umbilicus and had extensive subcutaneous hemorrhage at sites of previous venipuncture or mild trauma, and body cavity hemorrhage (hemothorax, hemoabdomen, and hemarthrosis), resulting in death. Breeding data indicated the coagulopathy was inherited as an autosomal recessive trait in sheep as in human beings, because approximately equal numbers of male and female affected lambs were observed, and the first report yielded 4 affected lambs of 15 lambs born (approximately 25%) to carrier ewes and a carrier ram.

The purpose of this study was to determine the underlying molecular defect in clinically affected lambs. We examined the relation of vitamin K oxidation and reduction because of the suggestion of altered vitamin K metabolism from the coagulation factor activities in a previous report and what is known about vitamin K (Fig. 1).


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Acknowledgement
 References
 
All reproductively active ewes were synchronized with vaginally inserted progesterone implants (Eazi-Breed CIDR; Pfizer, Groton, Connecticut) followed by removal at 17 days and injection of 500 units of pregnant mare serum (Sioux Biological Sioux Center, IA). The ewes were turned into a pen with a ram known to be heterozygous for the observed coagulation defect and that had been fitted with a marking crayon. All ewes were observed daily for marking by the ram, and delivery dates were calculated from the last known breeding date. Ewes were monitored 24 hours a day near the expected parturition dates to identify, sample, or treat affected lambs immediately after birth.

Coagulation parameters

An activated clotting time (ACT) was determined for each newborn lamb to identify clinically affected bleeding prone lambs. The ACT was performed within 1 hour of birth by using a Vacutainer (Becton Dickinson, Franklin Lakes, NJ) containing 6–10 mg of siliceous earth. Individual tubes were prewarmed to 37°C. Lambs with an ACT longer than 5 minutes were considered affected and were transfused with 120 ml of freshly thawed and prewarmed sheep plasma after blood was collected for evaluation. Affected lambs were sedated with 0.1 mg/kg subcutaneous xylazine, and the jugular vein was catheterized with a 22-gauge Insyte catheter (Becton Dickinson, Franklin Lakes, NJ). Plasma was slowly administered by using a 60-ml syringe attached to an extension set. Blood was collected for evaluation in 3.2% sodium citrate anticoagulant containing tubes for use in coagulation studies immediately before plasma infusion. These plasma samples were either immediately frozen and stored at –80°C or stored on ice, and coagulation studies were performed within 2 hours of blood collection. Prothrombin and partial thromboplastin times were determined with an MLA Electra 700 coagulation analyzer (Pleasantville, NY) and were compared with age-matched control lambs.

Coagulation factor activities

To confirm the bleeding phenotype and relationship to previously observed lambs from this flock, individual coagulation factor activities were determined by plotting respective coagulation times against a standard curve generated for each coagulation factor. Briefly, blood was collected from 20 unrelated adult Rambouillet ewes into 3.2% sodium citrate anticoagulant tubes (Becton Dickinson, Franklin Lakes, NJ). Plasma samples from all 20 ewes were pooled, frozen, and stored at –80°C before testing. Pooled sheep plasma was serially diluted with Owren's buffer (Sigma, St. Louis, MO) at 1 ° 2, 1 ° 4, 1 ° 8, 1 ° 16, 1 ° 32, 1 ° 64, and 1 ° 128. Standard curves for coagulation factors were determined by combining 50 µl of each serial diluted plasma sample from pooled normal sheep plasma with 50 µl of specific factor deficient plasma (George King Biomedical, Overland Park, KS) by using an MLA 700 coagulation analyzer. Times for each dilution of pooled normal sheep plasma were plotted on semilogarithmic paper with 2 cycles x 70 divisions. A straight line was drawn through the linear portion of each curve for each coagulation factor deficient plasma sample and serially diluted pooled normal sheep plasma sample. Plasma samples from affected and age-matched control lambs were appropriately diluted to occur on the linear segment of the standard curve. Activity of coagulation factors were determined by combining 50 µl of each appropriately diluted plasma sample with 50 µl of specific factor deficient plasma by using an MLA 700 coagulation analyzer and were plotted against standard curves for each respective coagulation factor.

Complete blood cell count, clinical chemistry, and necropsy

Blood was collected at the time of parturition from affected and control lambs. A complete blood cell count (CBC) was performed from ethylenediaminetetraacetic acid (EDTA) anticoagulated whole blood with an ADVIA 120 (Bayer, Tarrytown, NY). A differential leukocyte count was determined by manually counting a freshly prepared blood film stained with Wright-Giemsa. A routine clinical chemistry panel was performed from serum collected from a clot tube by using a Hitachi 917 automated chemistry analyzer (Roche Diagnostics, Indianapolis, IN). Two affected and 2 age- and sex-matched control lambs were euthanized with an intravenous overdose of sodium pentobarbital 8 days (R104 and CR102) and 80 days (G159 and CR108) after birth. Liver tissue was snap frozen in liquid nitrogen for evaluation of microsomal enzyme activity. All organ systems were sampled and collected in 10% neutral buffered formalin. Routine 5-µm histologic sections were prepared from paraffin-embedded tissue blocks, stained with hematoxylin and eosin, and evaluated under light microscopy.

Preparation of microsomes and determination of enzyme activities

Hepatocellular microsomes were prepared according to Kotkow et al.,17 using either fresh or snap frozen liver obtained from affected and age-matched control lambs. Briefly, liver samples were divided into ≤1-cm cubes, weighed to approximately 25 g, and combined with 25 ml of homogenization buffer (150 mM NaCl, 50 mM Tris-HCl, 5% [v/v] glycerol, 1 mM EDTA, 1 mM benzamidine, 1 mM phenylmethysufonyl fluoride, pH 7.5). Liver samples in homogenization buffer were disrupted by using a commercial blender and were subsequently homogenized by using a homogenizer fitted with a 7-mm saw-toothed generator (Pro Scientific Inc., Oxford, CT). The homogenate was strained through gauze into a 25 x 89-mm centrifuge tube. Tubes were centrifuged at 4°C for 10 minutes at 10,000 x g. The supernatant was filtered through gauze into a second centrifuge tube and spun at 4°C for 1 hour at 130,000 x g. The supernatant was discarded, and the pellet was resuspended in 3 ml of homogenization buffer. Microsomal protein concentration was determined according to the Lowry Method (Sigma Diagnostics, St. Louis, MO). All microsomal assays were performed at a concentration of 10 mg/ml unless stated otherwise.

Carboxylase activity was determined from standard reaction mixtures (125 µl) containing the following: 250 µg of microsomal protein, 0.8 M (NH4)2SO4, 28 mM 4-morpholine propanesulfonic acid (MOPS) at pH 7.5, 0.5M NaCl, 20 µl 1% (3-[3-(Cholamidopropy1) dimethylammonio]-1-proanesulfonate [CHAPS]), 3.6 mM Phe-Leu-Glu-Glu-Leu, 8 mM dithiothreitol (DTT), 5 µl NaH14CO3, 220 µM of vitamin K hydroquinone (K1H2), and 16 µm proIX. The propeptide activator of {gamma}-glutamyl carboxylase, proIX, was manufactured by Macromolecular Resources (Colorado State University, Ft. Collins, CO), based on residues –18 to –1 of the human proIX sequence.27 The mixture was incubated at 25°C for 30 minutes in sealed tubes. One milliliter of 10% trichloroacetic acid was added to stop the reactions. Unbound 14CO2 was removed by gently boiling the mixture for 10 minutes or until the volume was reduced by approximately 90%. Total incorporation of 14CO2 was determined by adding 6 ml of Ecolite scintillation cocktail (Fisher Scientific, Hampton, NH) and was counted for 5 minutes/sample on a Beckman LS 1801 scintillation counter. Data are expressed as dpm (degradations per minute) 14CO2 incorporated/250 µg microsomal protein.

Vitamin K epoxide reductase (KO) activity was performed as described previously.14 Vitamin KO was prepared according to the procedure of Tishler et al.32 Standard reaction mixtures (125 µl) contained 250 µg of microsomal proteins, 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.28% CHAPS, 0.12% phosphatidyl choline, 5 mM NaHCO2, 222 µM vitamin KO, and 6 mM DTT. No exogenous substrates were added. The extraction, purification, and analysis of plasma samples were performed as reported previously.14

Glucose-6-phosphatase activity was determined according to the methods of Burch et al.9 Reaction mixtures contained 100 µg of homogenized liver microsomes. Enzyme activity was determined by the reduction of NAD+ in the reserve reaction, where hexokinase converts glucose to glucose-6-phosphate. Spectrophotometer readings were made at time 0 and 15 minutes after the addition of 2 µg/ml hexokinase.

Vitamin K1 administration

Three affected lambs were transfused with ovine plasma, as above, and subsequently were administered 35 mg vitamin K1, subcutaneously every 24 hours. Two lambs (R102 and G160) were administered vitamin K on day 1 after plasma infusion, and 1 lamb (G159) was administered vitamin K beginning day 5 after plasma infusion.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Acknowledgement
 References
 
Coagulation parameters

All lambs with an ACT exceeding 5 minutes had markedly prolonged prothrombin and activated partial thromboplastin times and decreased vitamin K–dependent procoagulant factor activities compared with age-matched control lambs (Table 1). These data identified the homozygous affected lambs and confirmed that the defect was the same as previously reported.


View this table:
[in this window]
[in a new window]
  		Table 1. Coagulation data of affected and control lambs sampled within 1 hour of birth.

 
Complete blood cell count, clinical chemistry, and necropsy

The results of gross and microscopic examination of clinically affected lambs at necropsy were unremarkable except for a variable degree of subcutaneous, umbilical, and body cavity hemorrhage, most consistently hemarthrosis. Hemorrhage was most notable at sites of previous trauma or venipuncture. Thymic hemorrhage was not present in affected lambs. Serum biochemistry and CBC results, at parturition, were within the reference range for all parameters except for mildly elevated sorbitol dehydrogenase (25–29 IU/l; normal range 10–23 IU/l), which was attributed to mild periparturient hepatocellular injury.

Microsomal enzyme activities

Microsomes prepared from age-matched control lamb liver had incorporation of 14CO2 in the substrate, whereas microsomes from affected lambs had markedly diminished incorporation of 14CO2, indicating severely decreased {gamma}-glutamyl carboxylase activity (Table 2). DTT-dependent epoxide reductase activity (Table 3) and glucose-6-phosphatase activity (Table 2) from affected lambs and age-matched control lambs were equivalent.


View this table:
[in this window]
[in a new window]
  		Table 2. Liver microsomal glucose-6-phosphate and {gamma}-glutamyl carboxylase activity for normal control and affected bleeding lambs.

 

View this table:
[in this window]
[in a new window]
  		Table 3. Liver microsomal vitamin K epoxide reductase activity of affected and control lambs.

 
Response to vitamin K1 administration

Two lambs were administered 35 mg of Vitamin K1 subcutaneously immediately after the initial plasma transfusion and every 24 hours thereafter or beginning 5 days after the initial plasma infusion (lamb G159) and every 24 hours thereafter. Coagulation factor activities were little changed from 4 to 80 days after initial plasma infusion (Table 4) and daily vitamin K1 administration to affected lambs.


View this table:
[in this window]
[in a new window]
  		Table. 4 Coagulation factor activities after vitamin K1 administration to affected lambs and factor activity of age-matched normal lambs.

 
Defect incidence across multiple seasons

Approximately 10% of the lambs (5 lambs from a total of 51) born into this flock had an ACT exceeding 5 minutes. Three of these lambs were female, and 2 lambs were male.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Acknowledgement
 References
 
The fatal coagulopathy observed in the affected lambs in this report was the result of significantly reduced levels of vitamin K–dependent coagulation factor activity. Potential causes included aberrant vitamin K metabolism or transport, vitamin K antagonism, or hepatic disease. Investigation excluded hepatic disease and vitamin K antagonism as potential causes of the coagulation defect.2 We, therefore, analyzed hepatic microsomal enzymes of the vitamin K cycle and demonstrated markedly reduced activity of the enzyme {gamma}-glutamyl carboxylase in enzymatically active microsomes, while activity of epoxide reductase was similar between affected and control lambs. The evidence of enzymatically active microsomes was supported by similar glucose-6-phosphatase activity in control and affected liver microsomes.

The affected lambs described in this report had variably reduced activity of the VKD proteins. While coagulation factors IX and X had minimal activity, the activity of coagulation factors II and VII were consistently higher. Coagulation factor activities in normal sheep relative to humans have been reported and are similar16 and, therefore, is not considered to be a result of species variation between individual factor activities in affected lambs. Age-matched control lambs were used to eliminate age-associated differences in hemostatic indices reported in humans and horses.1,3 In addition, standard curves generated from normal sheep did not demonstrate an inhibitory phase for any of the coagulation factors tested, which excluded the notion of inadequate plasma dilution, contributing to relatively higher activity levels in coagulation factors II and VII. Interestingly, the prothrombin propeptide reportedly has the lowest affinity of the coagulation factors tested28 yet maintains the highest relative activity in affected lambs. Lin et al.18 propose that the rate of release of the propeptide appears to be the rate-determining step in substrate turnover; therefore, substrates whose propeptides have relatively low affinities for the carboxylase have increased rates of turnover. This scenario may explain the higher observed activity for factor II. The factor VII propeptide is unique in that it contains a diglutamate pair and appears to act as a glutamate substrate for the carboxylase. We cannot discount the fact that this glutamate pair may interfere with the relative affinity and subsequent activity of the coagulation factor. Unfortunately, the propeptide sequences of the ovine coagulation factors are not known, it is possible that species variation between the respective propeptide sequences may also be contributing to the reported propeptide affinities and influencing the individual factor activity in vivo.

Administration of 35 mg/day vitamin K1 (a dosage exceeding the reported requirement to counteract the effects of warfarin in newborn lambs22) to 3 of the affected lambs did not correct the coagulopathy or improve the VKD coagulation factor activities, and all lambs eventually succumbed to fatal bleeding. Vitamin K administration in some reports of human epoxide reductase deficiency,21 Devon Rex cats with defective {gamma}-glutamyl carboxylase activity19,25 and warfarin intoxication in lambs22 correct the associated coagulopathy. The molecular defect of {gamma}-glutamyl carboxylase in Devon Rex cats is presumed to be in a region of the enzyme associated with vitamin K and propeptide binding, and increased vitamin K concentration overcomes the decreased binding to {gamma}-glutamyl carboxylase and clinical coagulopathy.25 The molecular defect of {gamma}-glutamyl carboxylase in affected Devon Rex cats has never been identified.

The inheritance pattern of the bleeding phenotype is suggestive of an autosomal recessive trait. This flock had a lower than expected percentage of affected lambs for such an inheritance pattern. This discrepancy is likely the result of early embryonic loss similar to that reported in {gamma}-glutamyl carboxylase knock-out mice,35 prothrombin deficient mice,29 and factor V deficient mice.34

We determined that the observed coagulopathy in affected Rambouillet lambs is the result of markedly reduced activity of the enzyme {gamma}-glutamyl carboxylase. Determination of the underlying genetic defect will certainly lend insight into the carboxylase active site and expand our understanding of the structure and functional relations of {gamma}-glutamyl carboxylase.


   Acknowledgement
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
References
 
We gratefully acknowledge the financial support of the American Heart Association through Grant AHA 9951132Z.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Acknowledgement
 References
 

  1. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full term infant. Blood 70:165–172, 1987[Abstract/Free Full Text]
  2. Baker DC, Robbe SL, Jacobson L, Manco-Johnson MJ, Holler L, Lefkowitz J. Hereditary deficiency of vitamin-K-dependent coagulation factors in Rambouillet sheep. Blood Coagul Fibrinolysis 10:75–80, 1999[ISI][Medline]
  3. Barton MH, Morris DD, Crowe N, Collatos C, Prasse KW. Hemostatic indices in healthy foals from birth to one month of age. J Vet Diagn Invest 7:380–385, 1995[Abstract/Free Full Text]
  4. Berkner KL. The vitamin K-dependent carboxylase. J Nutr 130: 1877–1880, 2000[Abstract/Free Full Text]
  5. Bouchard BA, Furie B, Furie BC. Glutamyl substrate-induced exposure of a free cysteine residue in the vitamin K-dependent gamma-glutamyl carboxylase is critical for vitamin K epoxidation. Biochemistry 38:9517–9523, 1999[CrossRef][Medline]
  6. Brenner B, Sanchez-Vega B, Wu SM, Lanir N, Stafford DW, Solera J. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 92:4554–4559, 1998[Abstract/Free Full Text]
  7. Brenner B, Tavori S, Zivelin A, Keller CB, Suttie JW, Tatarsky I, Seligsohn U. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 75:537–542, 1990[ISI][Medline]
  8. Bristol JA, Ratcliffe JV, Roth DA, Jacobs MA, Furie BC, Furie B. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood 88:2585–2593, 1996[Abstract/Free Full Text]
  9. Burch HB, Narins RG, Chu C, Fagioli S, Choi S, McCarthy W, Lowry OH. Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation. Am J Physiol 235:F246–253, 1978
  10. Chung KS, Bezeaud A, Goldsmith JC, McMillan CW, Menache D, Roberts HR. Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood 53:776–787, 1979[Abstract/Free Full Text]
  11. Dowd P, Ham SW, Naganathan S, Hershline R. The mechanism of action of vitamin K. Annu Rev Nutr 15:419–440, 1995[CrossRef][ISI][Medline]
  12. Dowd P, Hershline R, Ham SW, Naganathan S. Vitamin K and energy transduction: a base strength amplification mechanism. Science 269:1684–1691, 1995[Abstract/Free Full Text]
  13. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93:1798–1808, 1999[Free Full Text]
  14. Gijsbers BL, Jie KS, Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr 76:223–229, 1996[CrossRef][ISI][Medline]
  15. Johnson CA, Chung KS, McGrath KM, Bean PE, Roberts HR. Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X. Br J Haematol 44:461–469, 1980[ISI][Medline]
  16. Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44:793–797, 1994[Medline]
  17. Kotkow KJ, Roth DA, Porter TJ, Furie BC, Furie B. Role of propeptide in vitamin K-dependent gamma-carboxylation. Methods Enzymol 222:435–449, 1993[ISI][Medline]
  18. Lin PJ, Jin DY, Tie JK, Presnell SR, Straight DL, Stafford DW. The putative vitamin K-dependent gamma-glutamyl carboxylase internal propeptide appears to be the propeptide binding site. J Biol Chem 277:28584–28591, 2002[Abstract/Free Full Text]
  19. Maddison JE, Watson AD, Eade IG, Exner T. Vitamin K-dependent multifactor coagulopathy in Devon Rex cats. J Am Vet Med Assoc 197:1495–1497, 1990[ISI][Medline]
  20. McMillan CW, Roberts HR. Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case. N Engl J Med 274:1313–1315, 1966[ISI][Medline]
  21. Oldenburg J, von Brederlow B, Fregin A, Rost S, Wolz W, Eberl W, Eber S, Lenz E, Schwaab R, Brackmann HH, Effenberger W, Harbrecht U, Schurgers LJ, Vermeer C, Muller CR. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 84:937–941, 2000[ISI][Medline]
  22. Pastoureau P, Vergnaud P, Meunier PJ, Delmas PD. Osteopenia and bone-remodeling abnormalities in warfarin-treated lambs. J Bone Miner Res 8:1417–1426, 1993[ISI][Medline]
  23. Pechlaner C, Vogel W, Erhart R, Pumpel E, Kunz F. A new case of combined deficiency of vitamin K dependent coagulation factors. Thromb Haemost 68:617, 1992[ISI][Medline]
  24. Saxena SP, Israels ED, Israels LG. Novel vitamin K-dependent pathways regulating cell survival. Apoptosis 6:57–68, 2001[CrossRef][ISI][Medline]
  25. Soute BA, Ulrich MM, Watson AD, Maddison JE, Ebberink RH, Vermeer C. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thromb Haemost 68:521–525, 1992[ISI][Medline]
  26. Spronk HM, Farah RA, Buchanan GR, Vermeer C, Soute BA. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 96:3650–3652, 2000[Abstract/Free Full Text]
  27. Stanley TB, Humphries J, High KA, Stafford DW. Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase. Biochemistry 38:15681–15687, 1999[CrossRef][Medline]
  28. Stanley TB, Jin DY, Lin PJ, Stafford DW. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem 274:16940–16944, 1999[Abstract/Free Full Text]
  29. Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmback K, Xiao Q, Bugge TH, Degen SJ. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A 95:7597–7602, 1998[Abstract/Free Full Text]
  30. Suttie JW. Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid. CRC Crit Rev Biochem 8:191–223, 1980[ISI][Medline]
  31. Suttie JW. The metabolic role of vitamin K. Fed Proc 39:2730–2735, 1980[ISI][Medline]
  32. Tishler M, Freser L, Wendler N. Hydro, oxido and other derivatives of vitamin K1 and related compounds. J Am Chem Soc 61:2866–2871, 1940[CrossRef]
  33. Wallin R. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect. Biochem J 236:685–693, 1986[ISI][Medline]
  34. Yang TL, Cui J, Taylor JM, Yang A, Gruber SB, Ginsburg D. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost 83:70–77, 2000[ISI][Medline]
  35. Zhu A, Raymond R, Zheng X, Westrick R, Furie BC, Furie B, Kaufman RJ, Ginsbug D. Abnormalities of development and hemostasis in gamma-carboxylase deficient mice. Blood 92:152a, 1998
Request reprints from Dr. Jeremy S Johnson, IDEXX Laboratories, 2825 KOVR Drive, West Sacramento, CA 95605 (USA). E-mail: jeremy-johnson{at}idexx.com





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J. S.
Right arrow Articles by Baker, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, J. S.
Right arrow Articles by Baker, D. C.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS